Com­pounders’ mo­tion for pre­lim­i­nary in­junc­tion de­nied in case over tirzepatide short­age

Com­pound­ing phar­ma­cies faced a ma­jor set­back in their case over the FDA’s de­ci­sion to re­move the obe­si­ty drug tirzepatide from its of­fi­cial short­age list. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER